Advances in Biomarker Discovery for Cardiovascular Disease—2nd Edition

Dear Colleagues,

Cardiovascular disease, a disorder affecting the heart and blood vessels, is one of the leading causes of death worldwide. It includes coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions, causing an estimated 17.9 million deaths annually. Addressing the early detection and eventual treatment of this noncommunicable disease is crucial for maintaining public health. Multiomics, including genomics, transcriptomics, proteomics, metabolomics, etc., for biomarker discovery are unequivocally powerful tools for elucidating the molecular mechanisms underlying cardiovascular disease, which helps to unravel novel diagnostic and therapeutic biomarker candidates. Sequencing-based genomics and transcriptomics, as well as mass-spectroscopy-based proteomics and metabolomic technologies, enable the unprecedented large-scale identification and quantification of DNAs, RNAs, proteins, peptides, post-translational modifications, and metabolites, providing critical insights into cardiovascular pathophysiology. This Special Issue will focus on the latest advancements in biomarker discovery for cardiovascular disease, aiming to establish earlier detection and therapy strategies.

We cordially invite authors working on this complex and promising field to submit their original research, communications, and review articles to Biomedicines. Topics of interest include, but are not limited to, the following:

• Genomics and transcriptomics studies in cardiovascular disease;
• Proteome and peptidome analysis in cardiovascular disease;
• Post-translational modification studies in cardiovascular disease;
• Metabolomics studies in cardiovascular disease;
• Novel biomarker discovery in cardiovascular disease;
• Identification of therapeutic targets for cardiovascular disease;
• Mass-spectrometry-based proteomics for heart and blood vessel pathophysiology;
• Development of medicines for cardiovascular disease.

Dr. Qin Fu
Dr. Haijun Liu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.